# Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

> **NCT06412718** · — · UNKNOWN · sponsor: **IRCCS Ospedale San Raffaele** · enrollment: 274 (estimated)

## Conditions studied

- Rare Diseases
- Aniridia
- Neurotrophic Keratopathy
- Limbal Stem Cell Deficiency
- Ocular Graft-versus-host Disease
- Ocular Cicatricial Pemphigoid
- EEC Syndrome
- Corneal Neovascularization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06412718
- **Lead sponsor:** IRCCS Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05
- **Primary completion:** 2025-04
- **Final completion:** 2026-04
- **Target enrollment:** 274 (ESTIMATED)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06412718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06412718, "Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06412718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*